Search hospitals > Michigan > Ann Arbor
University of Michigan
Claim this profileAnn Arbor, Michigan 48109
Global Leader in Thyroid Fibrosis
Global Leader in Lymphoma
Conducts research for Breast Cancer
Conducts research for Postprandial Fullness Syndrome
Conducts research for Uterine Tumors
1923 reported clinical trials
266 medical researchers
Summary
University of Michigan is a medical facility located in Ann Arbor, Michigan. This center is recognized for care of Thyroid Fibrosis, Lymphoma, Breast Cancer, Postprandial Fullness Syndrome, Uterine Tumors and other specialties. University of Michigan is involved with conducting 1,923 clinical trials across 2,177 conditions. There are 266 research doctors associated with this hospital, such as Rajen Mody, MD, MS, Elie G. Dib, Paul Swiecicki, and Rashmi Chugh, MD.Area of expertise
1Thyroid Fibrosis
Global LeaderCFTR positive
CFTR
rs3570920 TT positive
2Lymphoma
Global LeaderStage IV
Stage III
ARID1A positive
Top PIs
Rajen Mody, MD, MSC S Mott Children's Hospital7 years of reported clinical research
Expert in Neuroblastoma
Expert in Cancer
52 reported clinical trials
85 drugs studied
Elie G. DibGenesys Hurley Cancer Institute6 years of reported clinical research
Expert in Thyroid Cancer
Studies Multiple Myeloma
38 reported clinical trials
105 drugs studied
Paul SwiecickiUniversity of Michigan Comprehensive Cancer Center5 years of reported clinical research
Expert in Thyroid Cancer
Studies Melanoma
19 reported clinical trials
29 drugs studied
Rashmi Chugh, MDUniversity of Michigan5 years of reported clinical research
Expert in Soft Tissue Sarcoma
Studies Uterine Leiomyosarcoma
19 reported clinical trials
26 drugs studied
Clinical Trials running at University of Michigan
Multiple Myeloma
Ovarian Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Heart Failure
Myelofibrosis
Essential Thrombocythemia
Plasma Cell Neoplasm
Atopic Dermatitis
Elranatamab vs Lenalidomide
for Multiple Myeloma
The purpose of this study is to evaluate whether elranatamab monotherapy can provide clinical benefit compared to lenalidomide monotherapy (control) in participants with newly diagnosed multiple myeloma after undergoing autologous stem cell transplant. In Part 1 and Part 2 of the study, participants in the study will either receive elranatamab (arm A and C) as an injection under the skin at the study clinic or lenalidomide orally once daily at home (arm B). Participation in the study will be approximately five years
Recruiting2 awards Phase 38 criteria
Anitocabtagene Autoleucel
for Multiple Myeloma
The goal of this study (iMMagine-3) is to compare the study drug, anitocabtagene autoleucel to standard of care therapy (SOCT) in participants with relapsed/refractory multiple myeloma who have received 1 to 3 prior lines of therapy, including an anti-CD38 monoclonal antibody and an immunomodulatory drug. The primary objective of this study is to compare the efficacy of anitocabtagene autoleucel versus SOCT in participants with RRMM.
Recruiting2 awards Phase 33 criteria
Mezigdomide Combo vs. Pomalidomide Combo
for Multiple Myeloma
This trial is testing two drug combinations to find out which one is better and safer for patients with multiple myeloma that has come back or not responded to previous treatments. The drugs work together to kill cancer cells by stopping their growth, helping the immune system attack them, and making it harder for them to survive.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Michigan?
University of Michigan is a medical facility located in Ann Arbor, Michigan. This center is recognized for care of Thyroid Fibrosis, Lymphoma, Breast Cancer, Postprandial Fullness Syndrome, Uterine Tumors and other specialties. University of Michigan is involved with conducting 1,923 clinical trials across 2,177 conditions. There are 266 research doctors associated with this hospital, such as Rajen Mody, MD, MS, Elie G. Dib, Paul Swiecicki, and Rashmi Chugh, MD.
Where is University of Michigan located?
To reach the University of Michigan Hospital in Ann Arbor, Michigan from the North, use I-275 South to M-14 West, then US-23 South, exiting at Geddes Road (exit 39). Turn left onto Center Drive to the Patient/Visitor Parking Deck. From the West, take I-94, exit at "Ann Arbor" (Exit 172), follow Jackson Rd (becomes Huron) for 2.5 miles, turn left onto Glen, then right onto East Medical Center Drive to park in P2.
Who should I call to ask about financial aid or insurance network?
**University of Michigan Hospital - Financial Assistance and Insurance Inquiries**
- **Patient Financial Experience**: For billing and insurance queries, contact 855-855-0863 or 734-615-0863, Monday – Friday, 8 a.m. – 4 p.m.
- **Patient Financial Counselors**: For financial assistance, including the Financial Assistance Program, MSupport, reach out at 877-326-9155 (8 a.m. - 4 p.m., Monday-Friday) or email [mailto:[email protected]](mailto:[email protected]).
- **Health Information Management Department**: For information about MyUofMHealth, call 734-615-0872 (Monday - Friday 7 a.m. – 7 p.m., Saturday 8 a.m. – 1 p.m.).
- For specific concerns, contact the Patient Billing Office at 734-764-7380 or [mailto:uhs-busbill@med.umich.edu](mailto:uhs-busbill@med.umich.edu).
What insurance does University of Michigan accept?
The University of Michigan accepts a wide range of insurance plans, including but not limited to Medicare Advantage Plans, Community Blue PPO, Comprehensive Major Medical, and GradCare. Michigan Medicine is also in-network with numerous health insurance plans such as AARP (UnitedHealthcare) Medicare, Affordable Choices (SRC) Indemnity and PPO, and many UnitedHealthcare plans including Choice, Choice Plus, and Medicare Advantage PPO. For behavioral health benefits, it's advised to verify participation status with your insurance provider prior to scheduling services.
What awards or recognition has University of Michigan received?
The University of Michigan Hospital in Ann Arbor, Michigan, is renowned for its exceptional research and care, receiving numerous awards and funding opportunities. Notably, the Biosciences Initiative awarded five scientists for their groundbreaking biological sciences research. Additionally, the hospital offers various research recognition awards for faculty and staff, including the Research Faculty Recognition Award, which grants a $1,500 award for outstanding scholarly achievements, and eleven awards for research staff excellence.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.